ABSTRACT Mouse fibroblasts resistant to the drug rutamycin were isolated by selectively introducing BrdUrd into the mitochondrial genome of a line of mouse fibroblasts (clone 1 D) lacking a cytoplasmic thymidine kinase enzyme. The ATPase (ATP phosphohydrolase; EC 3.6.1.3) activity of mitochondria isolated from these cells was resistant to rutamycin. The rutamycin-resistant mutants were enucleated with cytochalasin B and fused with mouse A 9 cells resistant to 8-azaguanine and sensitive to rutamycin. Cytoplasmic hybrids, or cybrids, were selected as cells resistant to rutamycin and 8-azaguanine, and appeared at a high frequency. Other fusions between rutamycin-resistant nucleated cells and A 9 produced colonies at a much lower frequency. Finilly, fusions between enucleated clone 1 D cells and A 9 cells produced no rutamycin-resistant colonies. These results indicate that rutamycin resistance is a cytoplasmically inherited characteristic in this cell line.
Mitochondria acre formed by the close cooperation of two genetic systems. One of these involves nuclear DNA and the protein-synthesizing apparatus of the cell cytoplasm, while the other system is located in the mitochondria and consists of a much smaller DNA along with its own transcription and translation machinery (1) . Although it is clear that these two genetic systems are closely coordinated in vivo, very little is known about how this is accomplished. Re'cent evidence indicates, however, that several protein products are influenced by both genetic systems (2) . One of these protein products is the oligomycin-sensitive ATPase (ATP phosphohydrolase; EC 3.6.1.3).
The oligonhycin-sensitive ATPase from yeast mitochondria contains at least 10 distinct polypeptides (3, 4) . Five of these are associated with the cold-labile F1-ATPase, one is the oligomycin sensitivity conferring protein which links the F1 subunits to the remaining subunits (5) , and four are hydrophobic polypeptides tightly associated with the mitochondrial inner membrane (6) . The F1-ATPase of yeast is synthesized on cytoplasmic ribosomes, since it is present in cytoplasmic petite mutants (7) (8) (9) as well as in cells grown in the presence of chloramphenicol (8, 10) . Also, the Fl-ATPase and the oligomycin sensitivity conferring protein of intact yeast cells are labeled in the presence of radioactive precursor and chloramphenicol but not of cycloheximide (5, 6) . The four hydrophobic proteins, in contrast, are made by the protein-synthesizing machinery in the mitochondria, since they are labeled in the presence of cyclohexitnide but not in the presence of chloramphenicol (3, 6, 11) . Oligomycin does not inhibit purified F1-ATPase but, instead, appears to act on a site of the complex associated with the inner mitochondrial membrane (12) .
The role of mitochondrial DNA has been studied in simple The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. eukaryotes such as yeast, and oligomycin resistance along with other drug-resistance loci have been mapped on the yeast mitochondrial genome (13) . However, the role of mammalian mitochondrial DNA is less well understood and it is not clear whether it codes for some of the subunits of the oligomycinsensitive ATPase. Thus far, mouse and human cells resistant to chloramphenicol have been isolated, by using ethidium bromide as a mutagen specific for mitochondrial DNA (14) . Furthermore, chloramphenicol resistance has been shown to be cytoplasmically inherited in these cells, since the mutant phenotype could be transferred by enucleating such cells and fusing the cytoplasts with other cell lines (15, 16) .
In order to explore some of the other specific coding properties of the mitochondrial genome, a strain of mouse fibroblasts, line clone 1 D, was used. These cells are resistant to BrdUrd and lack a soluble cytoplasmic thymidine kinase present in wild-type cells, but do possess mitochondrial-specific thymidine kinase. Thus BrdUrd, when introduced into the medium, can be preferentially incorporated into their mitochondrial genome (17) . This provides the possibility of using BrdUrd as a mutagen, to direct mutagenesis at the mitochondrial genome. The results presented in this paper should complement those obtained with mitochondrially determined chloramphenicol-resistant mutants (15, 16 Cloning Procedure. The mutant cells were subcloned by diluting them to a concentration such that an average of one cell was distributed to each well of a Falcon microtest plate. These cells were grown in medium conditioned by growth of normal clone 1 D cells. The conditioned medium was filter sterilized and supplemented with 10% fetal calf serum, 2.0 mM L-glutamine, and 0.1 ug of rutamycin per ml.
Growth Curves. A number of 25-cm2 Falcon flasks were seeded with 1.5 X 105 cells each. On the following day varying concentrations of antibiotics were added. Cells from two flasks containing each concentration of the drug being tested were harvested and counted in a Coulter counter at intervals of several days.
Isolation of Mitochondria. Harvested cells were first washed in phosphate-buffered saline (8.5 mM Na2HPO4/1.6 mM NaH2PO4.H20/0.15 M NaCl at pH 7.5). All of the following operations were at 40. The cells were suspended in sucrose/ Tris/EDTA buffer (0.25 M sucrose/10 mM Tris.HCI/1 mM EDTA at pH 7.4) and homogenized with 15 strokes in a smooth glass-surfaced Potter-Elvehjem tissue grinder and a Teflon pestle. The homogenate was centrifuged at 1100 X g for 10 min to sediment nuclei, unbroken cells, and large cytoplasmic debris. The supernatant was sedimented at 17,000 X g for 20 min; the pellet of mitochondria thus obtained was washed with sucrose/Tris/EDTA buffer and recentrifuged at 17,000 X g for 20 min. Protein concentrations were determined according to Lowry et al. (19) . Mitochondria were stored frozen at -20°in sucrose/Tris/EDTA buffer until just before use.
ATPase Assay. ATPase was measured by the procedure of Tzagoloff (20) . The assay medium contained 50 Mmol of Trissulfate (pH 8.0), 4 Aumol of MgSO4, 10 Mmol of ATP, and an amount of enzyme that hydrolyzed 0.2-0.8 Mmol of ATP per min in a final volume of 1 ml. The reaction was carried out for 20 min at 300 and was terminated with 0.2 ml of 50% trichloroacetic acid; an aliquot of deproteinized solution was assayed for inorganic phosphate by the procedure of King (21) . Activity was expressed as ,ug of phosphorus generated/min per mg of protein.
Succinate Cytochrome c Reductase Assay. Succinate cytochrome c reductase activity was determined by measuring the change in optical density at 550 nm by the procedure of Rabinowitz and de Bernard (22) . Activity was expressed as Mmol of cytochrome c reduced/min per mg of protein.
Cytochrome Oxidase Assay. The method of Rabinowitz et al. was used for the measurement of cytochrome c oxidase (23) . The reaction rate was measured in units of min-1 mg of protein-1.
Cell Enucleation. Cells were enucleated by a modification of the technique described by Croce and Koprowski (24) . Cells were allowed to attach overnight to glass cylinders, and then were treated for 3 hr at 370 with medium containing 10MAg of cytochalasin B per ml. The cylinders were transferred to a SW 27 rotor and centrifuged at 10,000 rpm for 45 min at 250 with medium containing 5.0,ug of cytochalasin B per ml.
Cell Fusion. Cells were fused in mixed monolayer with polyethylene glycol 600 by the technique described by Pontecorvo (25) . The product of the fusion of an enucleated cell fragment or cytoplast and a whole cell will be referred to as a cytoplasmic hybrid or cybrid, while the fusion of two nucleated cells will be referred to as a hybrid. 
RESULTS
A typical growth curve for clone 1 D and mutant cells in the presence and absence of rutamycin is displayed in Fig. 1 . Other growth studies on these mutants indicated that they were also resistant to the antibiotics oligomycin, peliomycin, and ossamycin at a concentration of 0.1 Mg/ml; the parental clone 1 D cells were unable to divide even once at this concentration of any of these drugs, all of which are close structural analogs of rutamycin and bind to ATPase at a site identical to that of rutamycin (12) . Like the parental clone 1 D, the mutants however were found to be highly sensitive to the drug chloramphenicol, an inhibitor of mitochondrial protein synthesis, at a concentration of 0.5 mg/ml. This suggests that these cells still possess mitochondria, upon whose function they depend for growth.
Four clones of mutants were isolated from the initial population as described in Materials and Methods. Clones 1, 3, and 4 were able to grow in 1.0 Mg of rutamycin per ml while clone 
The ATPase activity from the cloned mutants was much less sensitive to rutamycin than that found in normal cells ( Fig. 2 and Table 2 ), although three of the four clones had less ATPase activity than the normal cells. The isolated mitochondria were also assayed for two terminal respiratory complexes, namely, succinate cytochrome c reductase and cytochrome c oxidase.
Mitochondria from the mutants had approximately the same activities as the normal cells (Table 2) . First, this indicates that comparable quantities of mitochondrial membranes were present in the various samples and'hence the lower levels of ATPase activity found in the mutants, especially clones 2 and 4, probably reflects the lower ATPase activity per unit mitochondrion rather than a reduction in the amount-of mitochondria present. Second, the cytochrome oxidase activities of these mutant clones suggest that some segments of the mitochondrial genome, those probably coding for cytochrome oxidase peptides, are normally functional. In order to demonstrate that the resistance of the mutants to rutamycin was cytoplasmically inherited, we enucleated and fused the resistant cells with nucleated A 9 cells that are resistant to 8-azaguanine (Fig. 3A) and sensitive to rutamycin (Fig. 3B ). Colonies were then maintained in 20 ,tg of 8-azaguanine per ml to select against any nucleated mutant cells that survived the cytochalasin B treatment (Fig. 3A) or any hybrid products resulting from such cells. Also 1.0 tig of rutamycin per ml was added to the medium to select against A 9 cells that either did not fuse with the enucleated cells or fused with other A 9 cells. Hence, the only cells capable of growing in this selection medium would be 8-azaguanine and rutamycin resistant, and presumably would result from A 9 cells having received rutamycin-resistance determinant(s) from the mutant cytoplast. The results of the fusion between enucleated rutamycinresistant cells and A 9 cells are shown in Table 3 . The colonies were counted after 2 weeks of growth in the selection medium and appeared at a high frequency. Some cultures were maintained in the selection medium, and cells continued to proliferate for many months.
In another experiment clone 1 D cells sensitive to rutamycin were enucleated, fused with A 9 cells, and grown in the selection medium (Table 3) . A small number of colonies appeared in some of the flasks, but these colonies grew no further after the first 2 weeks and died slowly while being maintained in the selection medium. That these colonies appeared at all was probably a reflection of the capacity of A 9 cells to grow for about two generations in medium with rutamycin. Hence continued rutamycin resistance depends upon the presence of rutamycin-resistance determinants derived from the mutant cytoplasms and is not merely due to an increase in the amount of cytoplasm relative to the nucleus in the cybrid.
In order to determine whether rutamycin resistance might have been transferred to A 9 cells by fusion with some of the remaining nucleated mutants that survived the cytochalasin B treatment, we performed fusions under identical rutamycin and 8-azaguanine selection conditions with nucleated A 9 and rutamycin-resistant clones (Table 3) . Although some colonies were demonstrable 2 weeks after fusion, clearly they appeared at a much lower frequency than that found with enucleated mutant cells. Some of these cultures were allowed to grow in the selection medium for 2 additional weeks, during which the number of colonies diminished slowly, indicating that a substantial number of these colonies were not viable. In contrast, all the cultures containing fusion products with enucleated mutant cells (cybrids) became confluent shortly after the first 2 weeks of growth-( Table 3 ). The most likely explanation for the survival and growth of a few hybrid colonies is that some mutant cells lost their X chromosome upon fusion and hence the resulting heterokaryon would no longer be sensitive to 8-azaguanine. This is reasonable since chromosomes are frequently eliminated during early cell divisions after fusion of two cells (26, 27 ). An alternate explanation might be that some of the A 9 cells acquired some other mutation, such as a membrane alteration, making them impermeable to rutamycin and hence viable in the selection medium.
Mitochondria were isolated from the cybrids resulting from fusion of enucleated rutamycin-resistant cells and A 9 cells and rutamycin-sensitive ATPase was assayed. The ATPase activity froifi the cybrids was much less sensitive to rutamycin than that found in normal cells or even in rutamycin-resistant cells (Fig.  2 and Table 2 ). The high resistance of cybrid ATPase activity to rutamycin may be a reflection of the fact that these cells were selected in 1.0,Mg of rutamycin per ml while the rutamycinresistant cells were grown in 0. The cross resistance of the mutants to the antibiotics efra- Cells were fused and plated in selective medium containing 1.0 .ug of rutamycin and 20 ,g of 8-azaguanine per ml. The prefix "en" denotes a culture previously treated with cytochalasin B to induce enucleation. Colonies growing on flasks in the selective medium were counted when clearly visible after 2 and 4 weeks. We estimate the accuracy of these counts to be +10%. * None of these cells were found to be viable upon replating.
Cell Biology: Lichtor and Getz peptin and leucinostatin is somewhat puzzling. The leucinostatin binding site is very close to that of rutamycin on the inner mitochondrial membrane and it is possible that a change in conformation at the rutamycin binding site could affect the ability of leucinostatin to attach to the ATPase. However, efrapeptin binds to the F1 subunits of the ATPase at a site quite distinct from that of rutamycin. This suggests that either these drugs are not able to enter the mitochondria of the mutants or that the ATPase complex in the mutants has undergone a major conformational change (see Note Added in Proof).
The isolation of cybrids in high frequency resulting from the fusion between enucleated rutamycin-resistant cells and A 9 cells upon selection in 8-azaguanine and rutamycin, coupled with the biochemical studies of ATPase activity in the isolated mitochondria of these cybrids, strongly suggests that the genetic information for rutamycin resistance resides in the cytoplasm of mouse cells. Control fusions between enucleated (clone 1 D) and nucleated (A 9) rutamycin-sensitive cells produced no rutamycin-resistant cells (Table 3) . Fusion between nucleated rutamycin-resistant and rutamycin-sensitive cells produced rutamycin-resistant hybrids at a low frequency. Consequently, the appearance of these rutamycin-resistant cybrids at such high frequencies could not be explained solely by the fusion of two nucleated cells nor by the increase in the amount of cytoplasm per nucleus.
In conclusion, this mutant, taken together with those resistant to chloramphenicol (14, 15, 28, 29) , provides a tool for further exploration of the role of mitochondrial DNA in mammalian cells. In particular, it adds in an important way to the potential for carrying out genetic studies on the mammalian mitochondrial genome. It also provides a probe for the role of mitochondrial ATP production in the physiology of mammalian cells in culture.
Note Added in Proof. ATPase 
